Global $45.2 Billion Markets for Vaccine Technologies,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
32
Global $45.2 Billion Markets for Vaccine Technologies, 2017-2021: Significant Regulatory Developments In Vaccine-Preventable Disease Products

Dublin, March 07, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Markets for Vaccine Technologies" report to their offering. The scope of this study entails the current market for human and animal vaccines. The report also includes regulatory aspects, current and developing technologies, market projections and market share. An analysis of patents, clinical trials, innovations and opportunities, as well as the latest trends is also discussed. Sales data for the global and regional markets were corroborated for the present and forecasted values based on statistical analysis. Regions are categorized into the United States, Europe and the emerging markets, which include India, China, Japan, South Korea, Taiwan, Canada, Africa, Australia and New Zealand. The application of vaccines in various diseases is discussed from both a commercial and R&D perspective.

Report Includes - An overview of the global market for human and animal (veterinary) vaccines - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021 - A review of vaccine technology and its challenges, innovations, opportunities and regulatory hurdles - Evaluations of market sizes and developments for vaccine classes (prophylactic and therapeutic), vaccine types (inactivated, conjugate, attenuated, recombinant vector, subunit, toxoid, combination and dendritic cells), vaccine end-users (humans and animals) and disease indications (infectious, cancer and allergy) - Examination of industry environment, strategies, market influences and driving forces - Identification of regional market sizes, prices and trends - Analysis of relevant patents - Profiles of major players in the industry

Key Topics Covered: 1: Introduction - Study Objectives - Reasons For Doing This Study - Contributions Of The Study And For Whom - Scope Of The Study - Methodology 2: Executive Summary 3: Overview - Definitions - The Immune System - How Vaccines Work - Types Of Immunity - Advantages Of Vaccination - History Of Vaccines - Types Of Vaccines - Infectious Diseases Preventable By Vaccines 4: Regulatory Aspects - Regulatory Aspects - World Health Organization (Who) Prequalified Vaccines - New Product Approvals - Recalls - Vaccine Shortage - Significant Regulatory Developments In Vaccine-Preventable Disease Products 5: New Developments - Alliances And Joint Ventures - New Product Launches 6: Market Analysis Of Human Vaccines - Market By Type - Market By Region 7: Market Analysis Of Animal Vaccines - Market Overview - Market Revenue - Animal Vaccines - Market By Type - Market By Region 8: Industry Structure - Market Leaders In Human Vaccine - Market Share Of Human Vaccine - Market Leaders In Animal Vaccine - Market Share Of Animal Vaccine 9: Market By Application For Human Vaccines - Prophylactic Vaccines - Therapeutic Vaccines - Meningococcal/Pneumococcal Diseases - Influenza (Seasonal And Pandemic Disease) - Pediatric Polio/Pertussis/Hib - Adult/Adolescent Booster Vaccines - Travel-Related And Other Endemic Diseases - Hpv Disease - Rotavirus Disease - Other Diseases - Market Share Of Applications 10: Patent Analysis - Patents By Year - Patents By Vaccine Type - Patents By Assignee's Country - Patents By Company - Patents By Assignee 11: Current Situation - Human Vaccines - Animal Vaccines 12: Company Profiles - Abbott Laboratories - Aeras Global - Astellas Pharma Inc. - Astrazeneca Plc - Baxter International Inc. - Bayer Animal Health - Bharat Biotech International Limited - Biological E. Ltd. - Bio-Manguinhos - Bioproperties Pty Ltd. - Boehringer Ingelheim Gmbh - Bul Bio - National Center Of Infectious And Parasitic Diseases Ltd. (Bb-Ncipd Ltd.) - Cadila Healthcare Ltd. (Zydus Cadila) - Ceva Sante Animale - China National Biotec Group (Cnbg) - Colorado Serum Company - CSL Limited - Elanco Animal Health - Emergent Biosolutions Inc. - Fatro S.P.A. - Genvec Inc. - Geneone Life Sciences Inc - Geovax - Glaxosmithkline Plc - Green Cross Corp - Institut Pasteur De Dakar - Japan BCG Laboratory - LG Life Sciences - Johnson And Johnson Inc - Merck & Co. Inc. - Merial S.A.S. - Novartis Pharma AG - Panacea Biotec Ltd. - Pfenex Inc. - Pfizer Inc. - Profectus Biosciences Inc. - PT Bio Farma - Sanofi Pasteur - Serum Institute Of India Limited - Statens Serum Institut - Valneva SE - Virbac - Zoetis Inc. For more information about this report visit http://www.researchandmarkets.com/research/gt...al_markets

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Vaccines

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 97

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
VILVA's Global Reach: Power Testing's Next Phase

Updated Category News Views 23

A Power Play on Global Markets Taking a page from its relentless pursuit of quality and innovation, VILVA Electronics is bolstering its foothold on the international stage. Based in Shenzhen, this savvy player is reaching out for strategic partners like fishing for that perfect bite, hoping to reel in catches that understand the nitty-gritty of the local ponds—their...

Continue Reading
AI Faces Accountability Trials in Business 2027

Updated Category News Views 105

Charting the AI Accountability Course In 2027, the corporate AI landscape won't be the Wild West anymore; it's morphing into a structured battlefield where the winners will be those who successfully enforce accountability. The hands-off, carte blanche days of AI are fading fast, and businesses are starting to scrutinize the AI tools they've been throwing money at. "The...

Continue Reading
Global Vineyards List: New Entrants & Rankings Unveiled

Updated Category News Views 212

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Continue Reading
Net at Work Enhances Offering with K&R Acquisition

Updated Category News Views 24

Net at Work Makes a Strategic Move Out of the blue, Net at Work, a prominent figure in the North American tech scene, zeroes in on boosting their expertise with the acquisition of K&R Consulting Group. It's all about expanding their horizons, and snagging K&R doesn't just double down on their ERP game, it broadens their client base in manufacturing, distribution, and...

Continue Reading
Goodyear's Strategic Shift: New Leadership, New Path

Updated Category News Views 100

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Continue Reading
Zions Bank Spurs Idaho's Small Biz Boom in 2026

Updated Category News Views 85

Riding the Small Business Tsunami in Idaho You don't hear it every day, but Idaho's small business scene is hotter than a frypan—a nod to the entrepreneurial fire blazing in the state, and Zions Bank is holding the torch. In 2026, despite dealing with the uphill battles of inflation, tariffs, and labor scarcity, those entrepreneurs still managed to carve out a spot at...

Continue Reading
California Credit Union's Toy Drive Brings Holiday Cheer

Updated Category News Views 44

California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 191

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Inside Kristallnacht: An XR Journey for a New World

Updated Category News Views 135

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Continue Reading

Top 5 Most Recently Viewed Articles

Getinge's Early 2025 Financial Results: Insights and Strategies

Updated Category News Views 521

Sales Growth and Performance Overview Getinge has reported a strong performance for the first quarter of 2025, characterized by an organic sales growth of 6.2%. Despite facing currency headwinds, the medical technology company's positive trajectory continues to impress. The rise in order intake, marked at 2.9%, further cements Getinge's position as a key player in the...

Continue Reading
UnitedHealth's 2025 Outlook: Insights Amid Industry Challenges

Updated Category News Views 1417

UnitedHealth's Anticipated 2025 Outlook Investors eagerly await significant insights into UnitedHealth Group's (NYSE: UNH) projections for 2025 as the company prepares to release its quarterly results. This anticipation follows the recent tragic event involving executive Brian Thompson, whose murder led to the cancellation of crucial investor day presentations. With the...

Continue Reading
Industrial Nitrogen Market Poised for Significant Growth Ahead

Updated Category News Views 126

The Promising Future of the Industrial Nitrogen Market Recent analyses indicate a bright future for the global industrial nitrogen market, which is anticipated to reach a value of USD 38.29 billion in the next few years. This projection reflects a strong compound annual growth rate (CAGR) of 6.1% based on recent evaluations. The growth trend is largely driven by...

Continue Reading
Akeso Showcases Groundbreaking IL-1RAP Antibody Research

Updated Category News Views 206

Akeso Showcases Groundbreaking IL-1RAP Antibody Research Akeso, Inc. (HKEX: 9926.HK) has unveiled promising data from preclinical studies of a new monoclonal antibody known as AK135. This innovative treatment specifically targets the IL-1 receptor accessory protein (IL-1RAP) and effectively blocks multiple pro-inflammatory pathways. The recent findings were presented at a...

Continue Reading
Vor Bio's Pioneering Research in IgA Nephropathy Presentation

Updated Category News Views 164

Vor Bio Unveils Groundbreaking IgA Nephropathy Study at ASN 2025 CAMBRIDGE, Mass. -- Vor Bio, a leader in clinical-stage biotechnology focused on autoimmune diseases, is set to make a significant impact at the upcoming American Society of Nephrology’s Kidney Week 2025. They will present clinical data from a Phase 3 study conducted in collaboration with RemeGen Co., Ltd,...

Continue Reading